Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Jaguar Health Inc's Business Segments
Jaguar Health Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2026
Reportable Segments
2
Largest Segment
Human Health Segment
Total Revenue
$ 1
Regions Reported
-
Revenue Share by Reportable Segment - Q2 FY2026
- Human Health Segment95.9%
- Animal Health Segment4.1%
Revenue by Reportable Segment - Q2 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Human Health Segment | $ 1 | 95.9% |
| Animal Health Segment | $ 0 | 4.1% |
Revenue by Product & Service Category - Q2 FY2026
- Mytesi98%
- Product96.5%
- License3.5%
- Neonorm0.6%
- Canalevia0%
Revenue by Product & Service Category - Q2 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Mytesi | $ 1 | 98% |
| Product | $ 1 | 96.5% |
| License | $ 0 | 3.5% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
2 more categories available
Sign in to unlock the full Jaguar Health Inc dataset.
Description of Jaguar Health Inc
Jaguar Health Inc. is a pharmaceutical company that is focused on developing innovative, plant-based medicines for various health conditions. The company is headquartered in San Francisco, California and was founded in 2013.
Jaguar Health's primary goal is to develop and commercialize products derived from the botanical diversity of rainforests. They aim to discover new therapeutic solutions for areas of high unmet medical need, particularly in the area of gastrointestinal health.
The company has developed a broad pipeline of potential drug candidates, which are derived from plants with medicinal properties. Their lead drug candidate is called Mytesi, which is an FDA-approved prescription medicine for the treatment of diarrhea in people living with HIV/AIDS.
Mytesi utilizes the active pharmaceutical ingredient crofelemer, which is derived from the Croton lechleri tree found in the Amazon rainforest. It works by modulating the secretion of fluid and electrolytes in the gastrointestinal tract, thereby reducing excessive fluid loss and improving symptoms of diarrhea.
Aside from Mytesi, Jaguar Health is also conducting clinical studies on other potential drug candidates. One of them is called Canalevia, which is being investigated as a treatment for the management of chemotherapy-induced diarrhea in dogs. Another drug candidate, called Equilevia, is being evaluated for its potential use in managing gastrointestinal issues in horses.
In addition to their drug development efforts, Jaguar Health also operates a commercialization division called Napo Pharmaceuticals. This division is responsible for marketing and distributing Mytesi to healthcare providers, pharmacies, and patients. They have a dedicated sales force that focuses on raising awareness about the product and expanding its market reach.
Jaguar Health has also established strategic partnerships with other companies and organizations to further advance their drug candidates. They collaborate with various research institutions and non-profit organizations, aiming to leverage their collective expertise and resources to accelerate the development and commercialization of their products.
Moreover, Jaguar Health is committed to sustainability and conservation efforts. They acknowledge the importance of preserving rainforests and the biodiversity they hold. The company works closely with local communities and indigenous people to support sustainable harvesting practices and protect the ecosystems that provide the raw materials for their drug candidates.
In conclusion, Jaguar Health Inc. is a pharmaceutical company dedicated to developing plant-based medicines for gastrointestinal health. Their lead drug candidate, Mytesi, has been approved by the FDA and is used in the treatment of diarrhea in HIV/AIDS patients. They also have a pipeline of potential drug candidates under investigation for various conditions and have a commercialization division focused on marketing and distributing their products. Furthermore, Jaguar Health emphasizes sustainability and collaboration to ensure the continued availability of these plant-based medicines.
Jaguar Health's primary goal is to develop and commercialize products derived from the botanical diversity of rainforests. They aim to discover new therapeutic solutions for areas of high unmet medical need, particularly in the area of gastrointestinal health.
The company has developed a broad pipeline of potential drug candidates, which are derived from plants with medicinal properties. Their lead drug candidate is called Mytesi, which is an FDA-approved prescription medicine for the treatment of diarrhea in people living with HIV/AIDS.
Mytesi utilizes the active pharmaceutical ingredient crofelemer, which is derived from the Croton lechleri tree found in the Amazon rainforest. It works by modulating the secretion of fluid and electrolytes in the gastrointestinal tract, thereby reducing excessive fluid loss and improving symptoms of diarrhea.
Aside from Mytesi, Jaguar Health is also conducting clinical studies on other potential drug candidates. One of them is called Canalevia, which is being investigated as a treatment for the management of chemotherapy-induced diarrhea in dogs. Another drug candidate, called Equilevia, is being evaluated for its potential use in managing gastrointestinal issues in horses.
In addition to their drug development efforts, Jaguar Health also operates a commercialization division called Napo Pharmaceuticals. This division is responsible for marketing and distributing Mytesi to healthcare providers, pharmacies, and patients. They have a dedicated sales force that focuses on raising awareness about the product and expanding its market reach.
Jaguar Health has also established strategic partnerships with other companies and organizations to further advance their drug candidates. They collaborate with various research institutions and non-profit organizations, aiming to leverage their collective expertise and resources to accelerate the development and commercialization of their products.
Moreover, Jaguar Health is committed to sustainability and conservation efforts. They acknowledge the importance of preserving rainforests and the biodiversity they hold. The company works closely with local communities and indigenous people to support sustainable harvesting practices and protect the ecosystems that provide the raw materials for their drug candidates.
In conclusion, Jaguar Health Inc. is a pharmaceutical company dedicated to developing plant-based medicines for gastrointestinal health. Their lead drug candidate, Mytesi, has been approved by the FDA and is used in the treatment of diarrhea in HIV/AIDS patients. They also have a pipeline of potential drug candidates under investigation for various conditions and have a commercialization division focused on marketing and distributing their products. Furthermore, Jaguar Health emphasizes sustainability and collaboration to ensure the continued availability of these plant-based medicines.
Jaguar Health Inc. is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for animals and humans. The company specializes in promoting the health and well-being of its products, particularly those derived from its proprietary plant-based compounds. Here’s an extensive description of the segments, products, and services they offer:
Segments:
1. Animal Health Segment:
- Jaguar Health is particularly known for its animal health division, creating natural, sustainable, and evidence-based solutions for veterinary care. This segment primarily targets gastrointestinal issues in pets and livestock.
- The focus is on both companion animals (such as dogs and cats) and larger animals (like horses and livestock).
2. Human Health Segment:
- While its initial focus was more prominent on animal health, Jaguar is expanding its reach into human health. This includes developing therapeutic solutions for gastrointestinal disorders and conditions such as chronic diarrhea and other related ailments.
- Their approach typically integrates plant-derived ingredients, harnessing the therapeutic potential found in nature.
Products:
1. Canalevia®:
- A significant product in Jaguar’s portfolio tailored for dogs. It is an orally administered, clinically validated, plant-based therapy designed to treat chemotherapy-induced diarrhea in dogs.
2. Mytesi®:
- Although primarily aimed at human health, this product is noteworthy as it targets symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS who are on antiretroviral therapy. It represents a bridge from animal health innovation to human health application, showcasing the companys versatility.
3. Equine Solutions:
- Jaguar has developed specialized formulations for horses, focusing on digestive health. These products provide support for gastrointestinal function and overall well-being in equines, particularly during stress-related conditions such as travel or competition.
Services:
1. Veterinary Support and Consultation:
- Jaguar Health provides support to veterinarians through educational resources on the use of their products. This includes information on addressing specific health challenges within animal populations.
2. Clinical Studies and Research:
- The company engages in continual research and clinical trials to advance the efficacy and safety of their products. They often release findings to ensure that veterinarians and consumers are updated with the latest scientific data.
3. Educational Materials:
- The organization creates resources for pet owners and veterinarians that encompass information on gastrointestinal health and the role of their therapies in managing these conditions.
4. Sustainability Initiatives:
- Jaguar Health emphasizes sustainability in its approach to product development, focusing on environmentally friendly practices in sourcing materials and production, which resonates with the growing consumer demand for sustainable and ethical products.
Market Approach:
Jaguar Health aims to carve out a niche by aligning its product offerings with the evolving trends in both animal and human health markets. They prioritize evidence-based solutions and aim to foster health through a holistic and natural approach, utilizing their unique plant-based formulations. Additionally, they are involved in creating partnerships with veterinarians and health professionals to promote their products effectively.
By integrating research, education, and high-quality products, Jaguar Health works towards enhancing the overall health of animals and humans alike, underpinning their mission to provide nature-derived therapeutic options for various health needs.
Segments:
1. Animal Health Segment:
- Jaguar Health is particularly known for its animal health division, creating natural, sustainable, and evidence-based solutions for veterinary care. This segment primarily targets gastrointestinal issues in pets and livestock.
- The focus is on both companion animals (such as dogs and cats) and larger animals (like horses and livestock).
2. Human Health Segment:
- While its initial focus was more prominent on animal health, Jaguar is expanding its reach into human health. This includes developing therapeutic solutions for gastrointestinal disorders and conditions such as chronic diarrhea and other related ailments.
- Their approach typically integrates plant-derived ingredients, harnessing the therapeutic potential found in nature.
Products:
1. Canalevia®:
- A significant product in Jaguar’s portfolio tailored for dogs. It is an orally administered, clinically validated, plant-based therapy designed to treat chemotherapy-induced diarrhea in dogs.
2. Mytesi®:
- Although primarily aimed at human health, this product is noteworthy as it targets symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS who are on antiretroviral therapy. It represents a bridge from animal health innovation to human health application, showcasing the companys versatility.
3. Equine Solutions:
- Jaguar has developed specialized formulations for horses, focusing on digestive health. These products provide support for gastrointestinal function and overall well-being in equines, particularly during stress-related conditions such as travel or competition.
Services:
1. Veterinary Support and Consultation:
- Jaguar Health provides support to veterinarians through educational resources on the use of their products. This includes information on addressing specific health challenges within animal populations.
2. Clinical Studies and Research:
- The company engages in continual research and clinical trials to advance the efficacy and safety of their products. They often release findings to ensure that veterinarians and consumers are updated with the latest scientific data.
3. Educational Materials:
- The organization creates resources for pet owners and veterinarians that encompass information on gastrointestinal health and the role of their therapies in managing these conditions.
4. Sustainability Initiatives:
- Jaguar Health emphasizes sustainability in its approach to product development, focusing on environmentally friendly practices in sourcing materials and production, which resonates with the growing consumer demand for sustainable and ethical products.
Market Approach:
Jaguar Health aims to carve out a niche by aligning its product offerings with the evolving trends in both animal and human health markets. They prioritize evidence-based solutions and aim to foster health through a holistic and natural approach, utilizing their unique plant-based formulations. Additionally, they are involved in creating partnerships with veterinarians and health professionals to promote their products effectively.
By integrating research, education, and high-quality products, Jaguar Health works towards enhancing the overall health of animals and humans alike, underpinning their mission to provide nature-derived therapeutic options for various health needs.